Joint Stock Company Grindeks is an international, vertically integrated pharmaceutical company. The main fields of action are research, development, manufacturing, and sales of original products, generics, and active pharmaceutical ingredients. The main therapeutic groups of Grindeks are cardiovascular, central nervous system, anti-cancer and diabetes medicines.
Looking for a particular Grindeks employee's phone or email?
The Grindeks annual revenue was $508 million in 2026.
Olga Bondare is the CFO of Grindeks.
256 people are employed at Grindeks.
Grindeks is based in Riga, Riga.
The NAICS codes for Grindeks are [3254, 32, 325, 32541].
The SIC codes for Grindeks are [28, 283].